(19)
(11) EP 2 041 101 A1

(12)

(43) Date of publication:
01.04.2009 Bulletin 2009/14

(21) Application number: 07733109.8

(22) Date of filing: 08.06.2007
(51) International Patent Classification (IPC): 
C07D 271/113(2006.01)
A61P 3/00(2006.01)
 A61K 31/4245(2006.01)
(86) International application number:
PCT/GB2007/002097
(87) International publication number:
WO 2007/144571 (21.12.2007 Gazette 2007/51)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 12.06.2006 GB 0611552

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • DOBSON, Andrew, Hornby
    Macclesfield, Cheshire SK10 4TG (GB)
  • GRUNDY, Walter
    Macclesfield, Cheshire SK10 4TG (GB)

   


(54) CRYSTALLINE FORM OF (TRANS-4- [ ( { 5- [ (3, 4 -DI FLUOROPHENYL) AMINO]-1,3, 4-OXADIAZOL-2-YL}CARBONYL) AMINO]PH ENYL } CYCLOHEXYL) ACETIC ACID